Intercytex Ltd is a UK-based regenerative medicine company established in 2000. Specializing in biotechnology and wellness beauty industries, it is dedicated to developing its lead product, ICX-RHY, to address various skin-related conditions such as Epidermolysis Bullosa (EB) and scar contractures. The company secured a £2.75M Venture Round investment on September 9, 2008. Despite the lack of specific details about the investors, this investment marked a significant milestone for Intercytex Ltd's growth and product development.
General Information
Get notified when Intercytex Ltd moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Intercytex Ltd
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Intercytex Ltd
Taxonomy: Regenerative Medicine, Cell Therapy, Skin Repair, Cell-Based Therapies, Clinical Trials, Stem Cell Research, Wound Healing, Skin Regeneration, Bioengineering, UK Biotech, Medical Innovation, Epidermolysis Bullosa Treatment, Scar Contractures Treatment
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 09 Sep 2008 | |
| Series D | •••••• | 5 |
|
01 Aug 2005 |
| Venture Round | •••••• | 1 |
|
01 Aug 2003 |
| Venture Round | •••••• | 1 |
|
21 Mar 2003 |
| Venture Round | •••••• | 1 | •••• •••• | 27 Feb 2000 |
Intercytex Ltd Alternatives & Competitors
A rapid and effective solution for clearing skin imperfections with a serum that removes dead skin c...
Science & Nature in Perfect Rhythm
FAQ About Intercytex Ltd
Don't just browse. Track.
Signal Tracker monitors Intercytex Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.